RecruitingNot ApplicableNCT05562232

The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms

The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms - a Pilot Study Protocol

Sponsor

Psychiatric Research Unit, Region Zealand, Denmark

Enrollment

45 participants

Start Date

Aug 1, 2023

Study Type

INTERVENTIONAL

Conditions

Mild Traumatic Brain Injury Concussion, Brain

Summary

The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.

Eligibility

Min Age: 20 YearsMax Age: 45 Years

Inclusion Criteria2

Have had PPCS for a minimum of six months and a maximum of 18 months at the start of the study.
Being between 20 and 45 years of age

Exclusion Criteria6

Elite athletes, as well as people who in general is physical active, at an intensity of moderat to high, for more than ten hours a week on average.
Participation in other interventions/treatment that could affect this study
Have had PPCS in:
=<6 months
=>18 months
Pregnant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTCreatine Monohydrate

Follows

Locations(1)

University of Southern Denmark

Odense, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05562232

Related Trials

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

NCT048673174 locations

TES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Symptoms

NCT074904181 location